article thumbnail

States That Restrict MMJ Access Are Interfering With Patients’ Rights, Study Shows

Veriheal

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access.

Access 98
article thumbnail

New Data Reveals Legal States Experienced Fewer Cases of EVALI

Veriheal

In 2019 the E-cigarette or Vaping-Use Associated Lung Injury (EVALI) outbreak was responsible for putting thousands of people in the hospital. An Analysis of Nationwide EVALI Data. Acknowledging this data, the study’s authors called for states to consider initiating home cultivation policies.

Data 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Frontier Data Launch “Cannabis Data Marketplace” Product

Cannabis Law Report

“New Frontier Data was the first firm to identify and address the need for data in what is now a global cannabis market. We have spent over five years building the only cannabis Big Data technology platform that is able to ingest, scrub, process and report millions of data points.”

Data 45
article thumbnail

London-based trading platform expands options for access to network

Cannabis Law Report

The new tool lets individual users and businesses connect with the entire Canxchange universe through a public chat feature, and gives them instant access to the company’s sales and support team. Under a limited access “light” version users can network and access data. Two options. Major traders.

Access 52
article thumbnail

Canada: J&J’s Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules ‘Not An Innovative Drug’

Cannabis Law Report

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98
article thumbnail

Maine: Medical Cannabis Market Is Third Largest in The State

NORML

Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. Although the state’s medical cannabis access program has been operational for some two decades, Maine officials only began tracking caregiver-related tax revenue in February of 2019.

Data 193
article thumbnail

New Frontier Data Publish Inaugural Reports

Cannabis Law Report

1-2019: Cannabis Consumer Retail Engagement. New Frontier Data’s Consumer Insight Series: Cannabis Consumer Retail Engagement , explores consumer purchasing habits and what influences them. New Frontier Data has identified five forces changing the consumer landscape: Expanding legal access. Therapeutic efficacy.

Data 45